$26.29
4.922.91%
At Close: -
$26.31
0.020.08%
After Hours: 7:22 PM EDT
15 minutes delayed
Comments
Loading...
Kiniksa Pharmaceuticals
KNSANASDAQ
Kiniksa Pharmaceuticals (KNSA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Quotes, Forecast and News Summary
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.
| Open | $23.25 |
| Close | $26.29 |
| Volume / Avg. | 3.80M / 395.03K |
| Day Range | 23.19 - 27.88 |
| 52 Wk Range | 14.12 - 22.65 |
| Market Cap | $1.87B |
| P/E Ratio | 164.54 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 81 |
| Short Interest | 14.64% |
| Days to Cover | 7.19 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Kiniksa Pharmaceuticals International Plc.
Sector
Health Care
Industry
Biotechnology
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on d...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kiniksa Pharmaceuticals (KNSA) stock?
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Who are Kiniksa Pharmaceuticals (KNSA) competitors?
Other companies in Kiniksa Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
What is the target price for Kiniksa Pharmaceuticals (KNSA) stock?
There is no analysis for Kiniksa Pharmaceuticals.
What is the forecast for Kiniksa Pharmaceuticals (KNSA) stock?
Kiniksa Pharmaceuticals has a consensus price target of $32.33.
Current stock price for Kiniksa Pharmaceuticals (KNSA)?
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $26.31 last updated Today at July 23, 2024 at 7:22 PM EDT.
Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?
There are no upcoming dividends for Kiniksa Pharmaceuticals.
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 23, 2024.
Is Kiniksa Pharmaceuticals (KNSA) going to split?
There is no upcoming split for Kiniksa Pharmaceuticals.
What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.